JP2003507413A - 徐放性鎮静催眠組成物およびそれに関連する方法 - Google Patents

徐放性鎮静催眠組成物およびそれに関連する方法

Info

Publication number
JP2003507413A
JP2003507413A JP2001518033A JP2001518033A JP2003507413A JP 2003507413 A JP2003507413 A JP 2003507413A JP 2001518033 A JP2001518033 A JP 2001518033A JP 2001518033 A JP2001518033 A JP 2001518033A JP 2003507413 A JP2003507413 A JP 2003507413A
Authority
JP
Japan
Prior art keywords
plasma concentration
tmax
sustained release
release formulation
sedative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001518033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003507413A5 (enExample
Inventor
ディー． ブラス キャンベル，
ダブリュー． ジェイ シエル，
Original Assignee
ニューロクライン バイオサイエンシーズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニューロクライン バイオサイエンシーズ， インコーポレイテッド filed Critical ニューロクライン バイオサイエンシーズ， インコーポレイテッド
Publication of JP2003507413A publication Critical patent/JP2003507413A/ja
Publication of JP2003507413A5 publication Critical patent/JP2003507413A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2001518033A 1999-08-26 2000-08-28 徐放性鎮静催眠組成物およびそれに関連する方法 Pending JP2003507413A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38444899A 1999-08-26 1999-08-26
US09/384,448 1999-08-26
PCT/US2000/023665 WO2001013895A2 (en) 1999-08-26 2000-08-28 Controlled-release sedative-hypnotic compositions and methods related thereto

Publications (2)

Publication Number Publication Date
JP2003507413A true JP2003507413A (ja) 2003-02-25
JP2003507413A5 JP2003507413A5 (enExample) 2007-10-11

Family

ID=23517364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001518033A Pending JP2003507413A (ja) 1999-08-26 2000-08-28 徐放性鎮静催眠組成物およびそれに関連する方法

Country Status (9)

Country Link
EP (2) EP1352647A1 (enExample)
JP (1) JP2003507413A (enExample)
AT (1) ATE241968T1 (enExample)
AU (1) AU7335500A (enExample)
DE (1) DE60003194T2 (enExample)
DK (1) DK1206248T3 (enExample)
ES (1) ES2199857T3 (enExample)
PT (1) PT1206248E (enExample)
WO (1) WO2001013895A2 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007023043A (ja) * 2005-07-20 2007-02-01 Orient Europharma Co Ltd 睡眠薬の放出制御医薬組成物及びその製造方法
JP2010521437A (ja) * 2007-03-15 2010-06-24 ポリケム・エスエイ 時間特異的遅延／パルス放出剤形
WO2011102506A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
JP2016183179A (ja) * 2004-10-28 2016-10-20 ヤゴテック アーゲー 不眠症の治療用薬剤の遅動型剤形
JP2016536371A (ja) * 2014-02-06 2016-11-24 シーケンシャル メディシン リミテッド 睡眠を補助する組成物及び方法
US9629808B2 (en) 2010-02-22 2017-04-25 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
US9827199B2 (en) 2012-09-03 2017-11-28 Daiichi Sankyo Company, Limited Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CN102670613A (zh) * 2011-03-16 2012-09-19 中国人民解放军军事医学科学院毒物药物研究所 用于改善茚地普隆溶出的药物组合物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
WO2001010868A1 (en) * 1999-08-10 2001-02-15 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654347A (en) * 1983-06-23 1987-03-31 American Cyanamid Company Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones
WO2001010868A1 (en) * 1999-08-10 2001-02-15 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016183179A (ja) * 2004-10-28 2016-10-20 ヤゴテック アーゲー 不眠症の治療用薬剤の遅動型剤形
JP2007023043A (ja) * 2005-07-20 2007-02-01 Orient Europharma Co Ltd 睡眠薬の放出制御医薬組成物及びその製造方法
JP2010521437A (ja) * 2007-03-15 2010-06-24 ポリケム・エスエイ 時間特異的遅延／パルス放出剤形
WO2011102506A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
US9629808B2 (en) 2010-02-22 2017-04-25 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
US9827199B2 (en) 2012-09-03 2017-11-28 Daiichi Sankyo Company, Limited Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
JP2016536371A (ja) * 2014-02-06 2016-11-24 シーケンシャル メディシン リミテッド 睡眠を補助する組成物及び方法

Also Published As

Publication number Publication date
ATE241968T1 (de) 2003-06-15
EP1352647A1 (en) 2003-10-15
PT1206248E (pt) 2003-11-28
EP1206248A2 (en) 2002-05-22
DE60003194T2 (de) 2004-06-17
WO2001013895A3 (en) 2001-09-27
AU7335500A (en) 2001-03-19
DE60003194D1 (de) 2003-07-10
ES2199857T3 (es) 2004-03-01
DK1206248T3 (da) 2003-09-29
WO2001013895A2 (en) 2001-03-01
EP1206248B1 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
US6485746B1 (en) Controlled-release sedative-hypnotic compositions and methods related thereto
AU737324B2 (en) Extended release formulations of erythromycin derivatives
US6458384B2 (en) Pharmaceutical with predetermined activity profile
CN103417505B (zh) 具有双相释药行为的石杉碱甲控释制剂及其制备方法
US20120276196A1 (en) Pharmaceutical Compositions of a Neuroactive Steroid and Methods of Use Thereof
US20030091632A1 (en) Controlled-release sedative-hypnotic compositions and methods related thereto
JP2003503341A (ja) 少なくとも一つの適時パルスを生ずる制御された放出用の医薬投与形態
HU226595B1 (en) Modified release multiple-units dosage composition
US11883374B2 (en) Lacosamide pharmaceutical composition and dosage form thereof
CN103976972B (zh) 酒石酸唑吡坦口服脉冲控释给药系统及其制备方法
JP2003507413A (ja) 徐放性鎮静催眠組成物およびそれに関連する方法
US20250025433A1 (en) Lacosamide pharmaceutical composition and dosage form thereof
US20250000805A1 (en) Valbenazine compositions
CN101143140A (zh) 单硝酸异山梨酯定时速释缓释制剂
JP3509637B2 (ja) 睡眠障害予防治療剤
WO2019011349A1 (zh) 芬乐胺晶b型、制备方法和其组合物与用途
KR20230152051A (ko) 멜라토닌을 포함하는 다층 펠릿의 제형(formulation of a multilayered pellet comprising melatonin)
HK1059888A (en) Controlled-release sedative hypnotic compositions and method related thereto
KR100341664B1 (ko) 제어방출형 아미트리프틸린 과립 및 그의 제조방법
CN111939139A (zh) 一种盐酸美金刚缓释和盐酸多奈哌齐速释胶囊及其制备方法
KR20180101539A (ko) 수면장애를 예방 및 치료하기 위한 약제학적 조성물
HK1145987A (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
HK1118202B (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070820

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070820

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110314

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110602